Novolin Ge Toronto 100 Unit (Insulin Injection Human Biosynthetic SOLUTION) 100 UNIT

Novolin GE Toronto 100 Unit is a human biosynthetic insulin injection designed for diabetes management. This 100 unit solution is manufactured by Novo Nordisk Canada Inc. and is suitable for intramuscular administration.

Strength

100 UNIT

Pack Size

10ML

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Novolin GE Toronto 100 Unit is primarily used for the management of diabetes. It helps regulate blood sugar levels in individuals who require insulin therapy. This insulin injection is often prescribed to help control both type 1 and type 2 diabetes, supporting overall glucose management.

Side Effects

Common effects of Novolin GE Toronto 100 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience hypoglycemia if blood sugar levels drop too low. It is important to monitor blood sugar levels regularly while using this insulin injection.

Precautions & Warnings

Handle Novolin GE Toronto 100 Unit with care, ensuring it is stored properly to maintain its effectiveness. Always follow the guidance of a healthcare professional regarding administration and monitoring. Be aware of the signs of hypoglycemia and have a plan in place to manage it.

Avoid Interactions

Novolin GE Toronto 100 Unit may interact with certain medications, including oral hypoglycemic agents and other drugs that affect blood sugar levels. Alcohol consumption can also impact the effectiveness of this insulin injection. Always consult a healthcare professional before combining it with other treatments.

Frequently Asked Questions

Novolin GE Toronto 100 Unit is used for the management of diabetes, helping to regulate blood sugar levels in individuals who require insulin therapy.

Novolin GE Toronto 100 Unit is typically administered intramuscularly. Follow the instructions provided by a healthcare professional for proper administration.

Common side effects may include localized reactions at the injection site and hypoglycemia. Regular monitoring of blood sugar levels is recommended.

Novolin GE Toronto 100 Unit may interact with certain medications. Consult a healthcare professional before combining it with other treatments.

Store Novolin GE Toronto 100 Unit as directed by the manufacturer to maintain its effectiveness. Typically, it should be kept at a controlled room temperature.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.